- Home
- Industry Reports
- Diagnostics
- Healthcare
- Middle East and Africa Nuclear Medicine Diagnostics Market – Size, Trends and Forecast (2024 – 2032)
Nuclear Medicine market is that which deals with medicine that utilises radiation to convey data about the functioning of persons particular organs to treat a disease. This market has gained huge popularity all around the world. Inclination and advancement in SPECT and PET analysis for nuclear medicine market and newer computer-based procedures for image analysis and display are boosting the market growth.
The Middle East and Africa Nuclear Medicine Diagnostics Market Segments Size & Growth:
The Middle East and Africa, nuclear medicine diagnostics market, is expected to reach $ 24.602 billion by 2024 from $ 12.534 billion in 2017 at a CAGR of 12.50% during the forecast 2018-2024. The key factors responsible for the market growth are newer computer-based procedures for image analysis and display, new 99mTc labeled agents for visualizing biologically significant events, increasing demand for SPECT and PET analysis development and integration of x-ray tomography into SPECT and so on. However, a shorter lifetime of radioisotopes and reimbursement issues are hampering the market growth.
The Middle East and Africa Nuclear Medicine Diagnostics Market Segments Share:
The Middle East and Africa, nuclear medicine diagnostics market, are divided into radioisotopes and application. On the basis of radioisotopes, the market is categorized into SPECT, PET, beta-emitters, alpha emitters and brachytherapy. Among these SPECT is having the demand and most significant share in the market as they are used in many nuclear applications such as nuclear cardiology procedures. However, SPECT will soon flip upside down due to the shortage of molybdenum-99 which in turn causes a deficiency of technetium-99 as it is by-products are included which are about to have a growth during the forecast period. The application is categorized into PET application, therapeutics application and diagnostics application. By geography, the Middle East and Africa are analyzed under various regions namely Saudi Arabia, Israel, UAE and South Africa.
The Middle East and Africa Nuclear Medicine Diagnostics Market Trends:
- GE Healthcare and Roche diagnostics come together to develop industry-first software integrating in-vivo and in-vitro diagnostics data with latest clinical research for improved patient outcomes.
- Puridify acquired GE Healthcare, and GE Healthcare provides transformational medical technologies and services.
- Gamma Medica announced that CE mark approval was received allowing for sale and distribution of Luma GEM.
- Gamma Medica makes the luma GEM molecular breast imaging system, a patient-friendly cost-effective tool that is poised to revolutionize battle against cancer.
- Gamma Medica partnered with medical imaging Inc. and capital X-Ray, Inc.
The Middle East and Africa Nuclear Medicine Diagnostics Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.
The major market players are
- GE Healthcare
- Agfa-gevaert N.V
- Gamma Medica Inc.
- CardiArc Ltd.
- Digirad Corporation
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Increasing demand for SPECT and PET analysis.
4.1.2 Development of better instruments.
4.1.3 New 99mTc labelled agents for visualising biologically significant events.
4.1.4. Newer computer-based procedures for image analysis and display.
4.2. Restraints
4.2.1 Shorter lifetime of radioisotopes.
4.2.2 Reimbursement issues.
4.2.3. Regulatory guidelines.
4.3. Opportunities
4.3.1 Increasing demand for PET imaging products which include hybrid PET-CT scanners will increase the growth of the market during the forecast.
4.4. Challenges
4.4.1. Shortage of molybdenum-99 isotope which in turn lead to a deficiency of technetium-99 which by-product of molybdenum.
5. The Middle East and Africa Nuclear Medicine Diagnostic Market – By Types of radioisotopes
5.1 Introduction
5.2 SPECT
5.2.1 Technetium
5.2.2 Thallium
5.2.3 Gallium
5.3 PET
5.3.1 Fluorine
5.3.2 Rubidium
5.4 Beta-emitters
5.4.1 Phosphorous 32
5.4.2 Iodine 131
5.4.3 Strontium 89
5.4.4 Yttrium 90
5.4.5 Samarium 153
5.4.6 Rhenium 186/188
5.5 Alpha emitters
5.5.1 Radium 223
5.5.2 Bismuth 213
5.6 Brachytherapy
5.6.1 Palladium 103
5.6.2 Iodine 125
5.6.3 Cesium 131
6. The Middle East and Africa Nuclear Medicine Diagnostic Market – By Application
6.1. Introduction
6.2 PET application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Neurology
6.3 Therapeutic application
6.3.1 Thyroid
6.3.2 Bone metastasis
6.3.3 Lymphoma
6.3.4 Endocrine tumors
6.4 Diagnostics application
6.4.1 SPECT application
6.4.1.1 Cardiology
6.4.1.2 Neurology
6.4.1.3 Thyroid
7. Middle East and Africa Nuclear Medicine Diagnostic Market – By Country
7.1. Introduction
7.2. Middle East and Africa
7.2.1.Middle East
7.2.2. Africa
8. Middle East and Africa Nuclear Medicine Diagnostic Market – Company Profiles
8.1 GE healthcare
8.2 Siemens healthcare
8.3 Cardinal health care
8.4 Triad isotope
8.5 Nordion Inc.
8.6 Eczacibasi-monrol nuclear products
8.7 Mallinckrodt Plc
8.8 Bracco imaging S.p.A
8.9 Advanced accelerator applications SA
8.10 Lantheus medical imaging Inc.
8.11 IBA molecular imaging
8.12 Bayer health care
9. Middle East and Africa Nuclear Medicine Diagnostic Market – Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Nuclear Medicine market is that which deals with medicine that utilises radiation to convey data about the functioning of persons particular organs to treat a disease. This market has gained huge popularity all around the world. Inclination and advancement in SPECT and PET analysis for nuclear medicine market and newer computer-based procedures for image analysis and display are boosting the market growth.
The Middle East and Africa Nuclear Medicine Diagnostics Market Segments Size & Growth:
The Middle East and Africa, nuclear medicine diagnostics market, is expected to reach $ 24.602 billion by 2024 from $ 12.534 billion in 2017 at a CAGR of 12.50% during the forecast 2018-2024. The key factors responsible for the market growth are newer computer-based procedures for image analysis and display, new 99mTc labeled agents for visualizing biologically significant events, increasing demand for SPECT and PET analysis development and integration of x-ray tomography into SPECT and so on. However, a shorter lifetime of radioisotopes and reimbursement issues are hampering the market growth.
The Middle East and Africa Nuclear Medicine Diagnostics Market Segments Share:
The Middle East and Africa, nuclear medicine diagnostics market, are divided into radioisotopes and application. On the basis of radioisotopes, the market is categorized into SPECT, PET, beta-emitters, alpha emitters and brachytherapy. Among these SPECT is having the demand and most significant share in the market as they are used in many nuclear applications such as nuclear cardiology procedures. However, SPECT will soon flip upside down due to the shortage of molybdenum-99 which in turn causes a deficiency of technetium-99 as it is by-products are included which are about to have a growth during the forecast period. The application is categorized into PET application, therapeutics application and diagnostics application. By geography, the Middle East and Africa are analyzed under various regions namely Saudi Arabia, Israel, UAE and South Africa.
The Middle East and Africa Nuclear Medicine Diagnostics Market Trends:
- GE Healthcare and Roche diagnostics come together to develop industry-first software integrating in-vivo and in-vitro diagnostics data with latest clinical research for improved patient outcomes.
- Puridify acquired GE Healthcare, and GE Healthcare provides transformational medical technologies and services.
- Gamma Medica announced that CE mark approval was received allowing for sale and distribution of Luma GEM.
- Gamma Medica makes the luma GEM molecular breast imaging system, a patient-friendly cost-effective tool that is poised to revolutionize battle against cancer.
- Gamma Medica partnered with medical imaging Inc. and capital X-Ray, Inc.
The Middle East and Africa Nuclear Medicine Diagnostics Market Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.
Expertise investment opportunities by an analyst to the individual and organization to have a better foothold in the market.
The major market players are
- GE Healthcare
- Agfa-gevaert N.V
- Gamma Medica Inc.
- CardiArc Ltd.
- Digirad Corporation
1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Increasing demand for SPECT and PET analysis.
4.1.2 Development of better instruments.
4.1.3 New 99mTc labelled agents for visualising biologically significant events.
4.1.4. Newer computer-based procedures for image analysis and display.
4.2. Restraints
4.2.1 Shorter lifetime of radioisotopes.
4.2.2 Reimbursement issues.
4.2.3. Regulatory guidelines.
4.3. Opportunities
4.3.1 Increasing demand for PET imaging products which include hybrid PET-CT scanners will increase the growth of the market during the forecast.
4.4. Challenges
4.4.1. Shortage of molybdenum-99 isotope which in turn lead to a deficiency of technetium-99 which by-product of molybdenum.
5. The Middle East and Africa Nuclear Medicine Diagnostic Market – By Types of radioisotopes
5.1 Introduction
5.2 SPECT
5.2.1 Technetium
5.2.2 Thallium
5.2.3 Gallium
5.3 PET
5.3.1 Fluorine
5.3.2 Rubidium
5.4 Beta-emitters
5.4.1 Phosphorous 32
5.4.2 Iodine 131
5.4.3 Strontium 89
5.4.4 Yttrium 90
5.4.5 Samarium 153
5.4.6 Rhenium 186/188
5.5 Alpha emitters
5.5.1 Radium 223
5.5.2 Bismuth 213
5.6 Brachytherapy
5.6.1 Palladium 103
5.6.2 Iodine 125
5.6.3 Cesium 131
6. The Middle East and Africa Nuclear Medicine Diagnostic Market – By Application
6.1. Introduction
6.2 PET application
6.2.1 Oncology
6.2.2 Cardiology
6.2.3 Neurology
6.3 Therapeutic application
6.3.1 Thyroid
6.3.2 Bone metastasis
6.3.3 Lymphoma
6.3.4 Endocrine tumors
6.4 Diagnostics application
6.4.1 SPECT application
6.4.1.1 Cardiology
6.4.1.2 Neurology
6.4.1.3 Thyroid
7. Middle East and Africa Nuclear Medicine Diagnostic Market – By Country
7.1. Introduction
7.2. Middle East and Africa
7.2.1.Middle East
7.2.2. Africa
8. Middle East and Africa Nuclear Medicine Diagnostic Market – Company Profiles
8.1 GE healthcare
8.2 Siemens healthcare
8.3 Cardinal health care
8.4 Triad isotope
8.5 Nordion Inc.
8.6 Eczacibasi-monrol nuclear products
8.7 Mallinckrodt Plc
8.8 Bracco imaging S.p.A
8.9 Advanced accelerator applications SA
8.10 Lantheus medical imaging Inc.
8.11 IBA molecular imaging
8.12 Bayer health care
9. Middle East and Africa Nuclear Medicine Diagnostic Market – Competitive Landscape
9.1. Market Share Analysis
9.2. Strategies Adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
11. Appendix
11.1. List of tables
11.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.